Glass John R 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Dec 18, 2017
Insider Transaction Report
Form 4
Glass John R
See Remarks
Transactions
- Purchase
Common Stock
2017-12-14$0.05/sh+84,100$4,533→ 84,100 total - Purchase
Common Stock
2017-12-14$0.05/sh+115,900$6,259→ 200,000 total